查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589600

药物发现外包市场：按工作流程、治疗领域、类型和最终用户划分 - 全球预测 2025-2030

Drug Discovery Outsourcing Market by Workflow, Therapeutics Area, Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药物发现外包市场规模为40.1亿美元，预计2024年将达到43.8亿美元，复合年增长率为9.39%，预计到2030年将达到75.3亿美元。

药物发现外包的调查范围是将药物研发过程委託给外部专业机构。药物发现复杂、成本高且耗时，因此製药公司需要利用外部专业知识来优化资源并加快进度。外包应用于药物开发的各个阶段，从标靶检验和先导化合物优化到临床前和临床试验管理。最终用途包括製药公司、生技公司、学术研究机构、CRO（委外研发机构）等。

主要市场统计
基准年[2023] 40.1亿美元
预测年份 [2024] 43.8亿美元
预测年份 [2030] 75.3亿美元
复合年增长率（%） 9.39%

市场洞察表明，製药公司研发支出的增加、需要广泛研究的严格法律规范以及新治疗技术的出现正在推动显着成长。主要影响因素包括遗传和生物技术研究的进步、需要创新治疗方法的慢性疾病的增加以及研究人才的全球化。量身订製的外包模式可以在个人化医疗、生技药品和基因组学领域提供竞争优势。学术界和工业界之间的合作可以透过缩小创新和商业化之间的差距来进一步推动成长。

然而，挑战包括知识产权管理、基于地区条件的品管以及应对因地区而异的监管情况。对外包伙伴的可靠性和专业知识的依赖以及时差可能妨碍沟通也会产生限制。

为了利用市场潜力，将人工智慧和机器学习整合到药物发现中进行预测分析，增强资料管理策略，并投资绿色化学来开发永续的药物製造方法，您可以将创新重点放在以下方面。此外，与高科技公司建立伙伴关係可以加速数位医疗和远端医疗解决方案的进步。市场是动态的，监管、创新和竞争不断交叉。因此，保持成长势头并利用新机会需要采取注重协作和技术整合的策略方法。

市场动态：揭示快速发展的药物发现外包市场的关键市场洞察

供需的动态交互作用正在改变药物发现外包市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 各种慢性病的增加和医疗支出的增加
    • 加大医药研发投入
    • 对学名药和生物创新的需求不断增长
  • 市场限制因素
    • 外包时的合规问题
  • 市场机会
    • 个人化医疗日益受到关注
    • 增加生技药品管道并扩大受託製造服务
  • 市场挑战
    • 严格的政府法规

波特五力：驾驭药物发现外包市场的策略工具

波特的「五力」框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药物发现外包市场的外部影响

外部宏观环境因素在塑造药物发现外包市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解药物发现外包市场的竞争状况

对药物发现外包市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 药物发现外包市场中的定位矩阵供应商绩效评估

FPNV定位矩阵是评估药物发现外包市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议 规划药物发现外包市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，药物发现外包市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 各种慢性病盛行率上升和医疗费用上涨
      • 加大医药研发投入
      • 对学名药和生物创新的需求不断增长
    • 抑制因素
      • 外包时的合规问题
    • 机会
      • 个人化医疗日益受到关注
      • 增加生物製药管道并扩大契约製造服务
    • 任务
      • 严格的政府法规
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章药物发现外包市场：依工作流程

  • 潜在客户识别和候选优化
  • 临床前开发
  • 目标识别和筛检
  • 目标检验和功能资讯学

第七章依治疗领域分類的药物发现外包市场

  • 抗感染
  • 心血管
  • 中枢神经系统
  • 皮肤科
  • 内分泌
  • 胃肠道
  • 泌尿生殖系统
  • 血液学
  • 免疫调节
  • 肿瘤学
  • 眼科
  • 疼痛和麻醉
  • 呼吸系统

第八章药物发现外包市场：按类型

  • 生物服务
  • 化学服务

第九章药物发现外包市场：依最终用户分类

  • 学术机构
  • 製药和生物技术公司

第十章美洲药物发现外包市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太药物发现外包市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的药物发现外包市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Charles River Laboratories
  • Curia Global, Inc.
  • Dalton Pharma Services
  • Eurofins DiscoverX Products
  • Evotec SE
  • GenScript Biotech Corporation
  • Jubilant Biosys Ltd.
  • Laboratory Corporation of America Holdings
  • Merck & Co., Inc.
  • Oncodesign Precision Medicine
  • PPD Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec
Product Code: MRR-742BD517D92E

The Drug Discovery Outsourcing Market was valued at USD 4.01 billion in 2023, expected to reach USD 4.38 billion in 2024, and is projected to grow at a CAGR of 9.39%, to USD 7.53 billion by 2030.

The scope of drug discovery outsourcing encompasses the delegation of research and development processes in pharmaceuticals to specialized external organizations. This practice is necessitated by the complex, costly, and time-consuming nature of drug discovery, compelling pharmaceutical companies to leverage external expertise to optimize resources and accelerate timelines. Outsourcing is applied across various stages of drug development, from target validation and lead optimization to preclinical and clinical trial management. The end-use scope includes pharmaceutical and biotechnology companies, academic and research institutions, and contract research organizations (CROs).

KEY MARKET STATISTICS
Base Year [2023] USD 4.01 billion
Estimated Year [2024] USD 4.38 billion
Forecast Year [2030] USD 7.53 billion
CAGR (%) 9.39%

Market insights reveal significant growth driven by the increasing R&D expenditure by pharmaceutical companies, stringent regulatory frameworks necessitating extensive research, and the advent of novel therapeutic technologies. Key influencing factors include advancements in genetic and biotechnological research, the rising prevalence of chronic diseases demanding innovative therapies, and the globalization of research talent pools. Opportunities abound in personalized medicine, biologics, and genomics, where tailor-made outsourcing models can offer competitive advantages. Collaborations across academia and industry players can further fuel growth by bridging the gap between innovation and commercialization.

However, challenges include managing intellectual property, maintaining quality control across geographical boundaries, and navigating regulatory landscapes that vary by region. Limitations also arise from dependency on the reliability and expertise of outsourcing partners and potential time zone differences hindering communication.

To capitalize on market potential, innovation could focus on integrating artificial intelligence and machine learning for predictive analytics in drug discovery, enhancing data management strategies, and investing in green chemistry to develop sustainable drug production methodologies. Additionally, nurturing partnerships with tech companies can drive advancements in digital health and telemedicine solutions. The market is dynamic, marked by a constant interplay of regulation, innovation, and competition, which necessitates a strategic approach focusing on collaboration and technological integration to maintain growth momentum and capitalize on emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Discovery Outsourcing Market

The Drug Discovery Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of various chronic diseases coupled with rising healthcare expenditure
    • Increasing pharmaceutical R&D investment
    • Rising demand for generic drugs and biologic innovation
  • Market Restraints
    • Compliance issues while outsourcing
  • Market Opportunities
    • Increased focus on personalized medicine
    • Growing number of biologics pipeline and growing contract manufacturing service
  • Market Challenges
    • Stringent government regulations

Porter's Five Forces: A Strategic Tool for Navigating the Drug Discovery Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Discovery Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Discovery Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Discovery Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Discovery Outsourcing Market

A detailed market share analysis in the Drug Discovery Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Discovery Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Discovery Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Discovery Outsourcing Market

A strategic analysis of the Drug Discovery Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Charles River Laboratories, Curia Global, Inc., Dalton Pharma Services, Eurofins DiscoverX Products, Evotec SE, GenScript Biotech Corporation, Jubilant Biosys Ltd., Laboratory Corporation of America Holdings, Merck & Co., Inc., Oncodesign Precision Medicine, PPD Inc., Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Workflow, market is studied across Lead Identification & Candidate Optimization, Preclinical Development, Target Identification & Screening, and Target Validation & Functional Informatics.
  • Based on Therapeutics Area, market is studied across Anti-Infective, Cardiovascular, Central Nervous System, Dermatology, Endocrine, Gastrointestinal, Genitourinary System, Hematology, Immunomodulation, Oncology, Ophthalmology, Pain & Anesthesia, and Respiratory System.
  • Based on Type, market is studied across Biology Services and Chemistry Services.
  • Based on End-User, market is studied across Academic Institutes and Pharmaceutical & Biotechnology companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of various chronic diseases coupled with rising healthcare expenditure
      • 5.1.1.2. Increasing pharmaceutical R&D investment
      • 5.1.1.3. Rising demand for generic drugs and biologic innovation
    • 5.1.2. Restraints
      • 5.1.2.1. Compliance issues while outsourcing
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased focus on personalized medicine
      • 5.1.3.2. Growing number of biologics pipeline and growing contract manufacturing service
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Discovery Outsourcing Market, by Workflow

  • 6.1. Introduction
  • 6.2. Lead Identification & Candidate Optimization
  • 6.3. Preclinical Development
  • 6.4. Target Identification & Screening
  • 6.5. Target Validation & Functional Informatics

7. Drug Discovery Outsourcing Market, by Therapeutics Area

  • 7.1. Introduction
  • 7.2. Anti-Infective
  • 7.3. Cardiovascular
  • 7.4. Central Nervous System
  • 7.5. Dermatology
  • 7.6. Endocrine
  • 7.7. Gastrointestinal
  • 7.8. Genitourinary System
  • 7.9. Hematology
  • 7.10. Immunomodulation
  • 7.11. Oncology
  • 7.12. Ophthalmology
  • 7.13. Pain & Anesthesia
  • 7.14. Respiratory System

8. Drug Discovery Outsourcing Market, by Type

  • 8.1. Introduction
  • 8.2. Biology Services
  • 8.3. Chemistry Services

9. Drug Discovery Outsourcing Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Institutes
  • 9.3. Pharmaceutical & Biotechnology companies

10. Americas Drug Discovery Outsourcing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Drug Discovery Outsourcing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Drug Discovery Outsourcing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Charles River Laboratories
  • 2. Curia Global, Inc.
  • 3. Dalton Pharma Services
  • 4. Eurofins DiscoverX Products
  • 5. Evotec SE
  • 6. GenScript Biotech Corporation
  • 7. Jubilant Biosys Ltd.
  • 8. Laboratory Corporation of America Holdings
  • 9. Merck & Co., Inc.
  • 10. Oncodesign Precision Medicine
  • 11. PPD Inc.
  • 12. Thermo Fisher Scientific Inc.
  • 13. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. DRUG DISCOVERY OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DRUG DISCOVERY OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DRUG DISCOVERY OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG DISCOVERY OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DISCOVERY OUTSOURCING MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD IDENTIFICATION & CANDIDATE OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION & SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET VALIDATION & FUNCTIONAL INFORMATICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY GENITOURINARY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY IMMUNOMODULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PAIN & ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESPIRATORY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMISTRY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. DRUG DISCOVERY OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 201. DRUG DISCOVERY OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023